Loading clinical trials...
Loading clinical trials...
A Swiss Prospective Multicenter Longitudinal Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children: An Explorative Study
Conditions
Locations
2
Switzerland
KSA
Aarau, Switzerland
UKBB
Basel, Switzerland
Start Date
August 13, 2024
Primary Completion Date
June 30, 2026
Completion Date
June 30, 2026
Last Updated
March 6, 2025
NCT07070219
NCT06649253
NCT02769975
NCT04322435
NCT01661387
NCT06435481
Lead Sponsor
University Children's Hospital Basel
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions